Nicotine & cancer
This article was originally published in The Tan Sheet
Transdermal and oral exposure to nicotine could contribute to cancer, researchers state in the January Journal of Clinical Investigation. Phillip Dennis, NCI, et al., find "sustained exposure to nicotine might alter the phenotype of endothelial and/or epithelial cells in undetectable, premalignant lesions," suggesting long-term exposure to smoking cessation drugs such as patches, gum could be harmful. NRT marketers Pharmacia, GSK point to lack of clinical evidence drugs cause cancer. "Tobacco dependence experts agree that the risks of developing cancer from short-term NRT use to aid smoking cessation are insignificant compared to the risks of developing cancer from cigarette smoking," Pharmacia states...
You may also be interested in...
A consortium of Swiss providers, patient groups and health care trade bodies is imploring the federal council to avert a looming patient care crisis in Switzerland if the EU MRA cannot be agreed.
China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.
Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.